| Product Name | MF | CAS | Details |
|---|
| Gimatecan | C25H25N3O5 | 292618-32-7 | Details |
| Ethyl 4-chloro-2-methylquinoline-6-carboxylate | C13H12ClNO2 | 100375-87-9 | Details |
| BIM-46187 | C44H58N8O2S2 | 892546-37-1 | Details |
| 5-Amino-2-chloro-4,6-dimethylpyridine-3-carbonitrile | C8H8ClN3 | 6972-36-7 | Details |
| N-(Prop-2-en-1-yl)benzenesulfonamide | C9H11NO2S | 50487-70-2 | Details |
| 6-Amino-4-hydroxypyridine-2-carboxylic acid | C6H6N2O3 | 1393552-65-2 | Details |
| Indole-3-propionic acid | C11H11NO2 | 830-96-6 | Details |
| N-(2-Phenylethyl)-1,3,4-thiadiazol-2-amine | C10H11N3S | 1342738-90-2 | Details |
| Rheumatoid Factor IgM ELISA kit | Details |
| [3-(2-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol | C10H10N2O3 | 926242-11-7 | Details |
| CMVpp65 - 65 (TRNPQPFMRPHERNG) | Details |
| 2-(1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-1,2,3,4-tetrahydroquinolin-4-yl)acetic acid | 2138174-69-1 | Details |
| 3-Methoxy-1,2-thiazole-4-carbonitrile | C5H4N2OS | 31815-41-5 | Details |
| Des-n-Octanoyl-[Ser3]-Ghrelin (Human, 1-18) | C88H143N31O29 | Details |
| NHEDC1 antibody | Details |
| 3,5-Dichloro-4-methylbenzene-1-sulfonyl chloride | C7H5Cl3O2S | 24653-79-0 | Details |
| H-QASQEVKNW-OH | Details |
| H-QGVAEAAGK^-OH | Details |
| Zapoterin | 35796-71-5 | Details |
| Ethyl 4-bromo-3-(bromomethyl)benzoate | C10H10Br2O2 | 347852-72-6 | Details |
| 3,5-Dichloro-4-fluorophenylacetonitrile | C8H4Cl2FN | 1804421-31-5 | Details |
| 2-(2-Bromoethyl)-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one | C8H8BrN3O | 1000932-43-3 | Details |
| {2-Methoxy-5-[(methylsulfanyl)methyl]phenyl}boronic acid | C9H13BO3S | 1334684-23-9 | Details |
| 2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethyl)benzonitrile | C10H5F3N4 | 1094368-55-4 | Details |
| 1,3-bis(4-methylphenyl)-5-(3-thienylmethylene)-1,3-diazaperhydroine-2,4,6-trione | C23H18N2O3S | 1024430-99-6 | Details |
| 2-[(3,5-Dichlorophenyl)formamido]-2-methylpropanoic acid | C11H11Cl2NO3 | 31110-41-5 | Details |
| Synaptophysin Blocking Peptide | Details |
| 1,2,3,4-Tetra-O-benzyl-6-O-triisopropylsilyl-a-D-mannopyranose | C43H56O6Si | Details |
| 4-[3-(Dimethylamino)propoxy]-3,5-difluoroaniline | C11H16F2N2O | 1221723-98-3 | Details |
| HIV-1 reverse transcriptase (A2-YI9) | Details |
| (5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione | C8H10N2O2S2 | 72744-67-3 | Details |
| (S)-1-(Methylamino)-2-propanol Hydrochloride | C4H11NO | 70377-76-3 | Details |
| 2,6-Dichloro-4-fluoroiodobenzene | C6H2Cl2FI | 939990-10-0 | Details |
| 5-Cyano-N,N-dimethylpyridine-2-carboxamide | C9H9N3O | 1343225-44-4 | Details |
| 8-Oxaspiro[4.5]decan-1-ol | C9H16O2 | 1690751-54-2 | Details |
| Diethyl benzylphosphonate | C11H17O3P | 1080-32-6 | Details |
| 2-Bromo-N-phenylaniline | C12H10BrN | 61613-22-7 | Details |
| rac-tert-Butyl N-{[(3R,4S)-4-phenylpyrrolidin-3-yl]methyl}carbamate | C16H24N2O2 | 154206-10-7 | Details |
| NBN antibody | Details |
| C.I.Solvent Orange 41 | 61901-91-5 | Details |
| Ranalexin | C97H167N23O22S3 | 155761-99-2 | Details |
| 1,3,5-Tri-O-benzoyl-2-deoxy-2-fluoro-a-D-ribofuranose | C26H21FO7 | 704916-12-1 | Details |
| 2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}(2,2,2-trifluoroethyl)amino)acetic acid | C19H16F3NO4 | 1486953-68-7 | Details |
| 2-(2-Bromophenyl)piperidine | C11H14BrN | 383128-15-2 | Details |
| Methyl 2-hydroxy-3-methoxypropanoate | C5H10O4 | 54927-70-7 | Details |
| 5-(2-Fluorophenyl)-4-methyl-4H-1,2,4-triazole-3-thiol | C9H8FN3S | 114058-90-1 | Details |
| 1-Ethyl-3,5-bis(trifluoromethyl)-1H-pyrazole-4-carboxylic acid | C8H6F6N2O2 | 1384431-42-8 | Details |
| Mrps33 antibody | Details |
| Neosolaniol | C19H26O8 | 36519-25-2 | Details |
| O-tert-Butyl-L-tyrosine | C13H19NO3 | 18822-59-8 | Details |
| Apratastat | C17H22N2O6S2 | 287405-51-0 | Details |
| N1-Benzyl-N1,N3-dimethyl-1,3-propanediamine | C12H20N2 | 60630-68-4 | Details |
| 1,2,3,4,4a,5,6,7-Octahydro-2,7-naphthyridin-1-one | 2287317-74-0 | Details |
| N-Desmethyl clozapine | C17H17ClN4 | 6104-71-8 | Details |
| Benzyl 4-benzyloxybenzoate | C21H18O3 | 56442-22-9 | Details |
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | C12H15N | 28289-54-5 | Details |
| 5-Oxo-1-(pyridin-3-yl)pyrrolidine-3-carboxylic acid | C10H10N2O3 | 914637-52-8 | Details |
| 4-(2,4-Dichlorophenyl)-3-methyl-1H-pyrazol-5-amine hydrochloride | C10H10Cl3N3 | 232615-99-5 | Details |
| DRAP1 antibody | Details |
| (2R)-2-Amino-N,N-dimethylbutanamide hydrochloride | C6H15ClN2O | 2137146-05-3 | Details |
| 4-Methylumbelliferyl-beta-D-glucopyranoside | C16H18O8 | 18997-57-4 | Details |
| 4-Acetyl-3,4-dihydro-1H-quinoxalin-2-one | C10H10N2O2 | 120589-86-8 | Details |
| MBP146-78 | C21H22FN3 | 188343-77-3 | Details |
| 4-bromo-3-(methylthio)benzoic acid | C8H7BrO2S | 851334-60-6 | Details |
| 6-Bromohexanamide | C6H12BrNO | 57817-55-7 | Details |
| Ethyl(1-methoxypropan-2-yl)amine hydrochloride | C6H16ClNO | 1170401-56-5 | Details |
| 4-(1H-Indazol-1-yl)aniline | C13H11N3 | 169781-26-4 | Details |
| 1-(Pyridin-3-yl)-1H-pyrrole-3-carbaldehyde | C10H8N2O | 342601-15-4 | Details |
| 2-[[1-(Methylamino)-2-nitroethenyl]amino]-ethanethiol | C5H11N3O2S | 66357-41-3 | Details |
| (1R)-1-(5-Fluoropyridin-2-yl)ethan-1-ol | C7H8FNO | 1202070-41-4 | Details |
| 4-(Aminomethyl)benzene-1-sulfonic acid | C7H9NO3S | 2393-24-0 | Details |
| TTC27 antibody | Details |
| N-Methyl-1,2-benzothiazol-3-amine | C8H8N2S | 7716-58-7 | Details |
| 3-(Phenoxymethyl)-N-(propan-2-yl)-1,2,4-oxadiazol-5-amine | C12H15N3O2 | 1271566-09-6 | Details |
| pE-VHHQK-OH | Details |
| 3,4-Dimethyl-2,3-dihydro-1H-inden-1-one | C11H12O | 35322-82-8 | Details |
| L-Daunosamine | C6H13NO3 | 749168-24-9 | Details |
| ARHGEF18 antibody (HRP) | Details |
| 3-Methyl-2-(4-methylpiperazin-1-yl)butan-1-amine | C10H23N3 | 929343-94-2 | Details |
| NXNL2 Blocking Peptide | Details |
| L-Cysteinesulfinic acid | C3H7NO4S | 1115-65-7 | Details |
| 4,6,12-Triazatricyclo[7.2.1.0,2,7]dodeca-2,4,6-triene | C9H11N3 | 412016-37-6 | Details |
| tert-Butyl N-[(1R)-1-carbamoylpropyl]carbamate | C9H18N2O3 | 1807941-72-5 | Details |
| 4-[(Methylsulfanyl)methyl]pyridin-2-amine | C7H10N2S | 179554-98-4 | Details |
| Saccharin-d4 | C7H5NO3S | 1189466-17-8 | Details |
| VASP antibody (Ser157) | Details |
| 2-(5-Chlorothiophen-2-yl)-6-methoxyquinoline-4-carboxylic acid | C15H10ClNO3S | 897565-19-4 | Details |
| Secretin (Porcine) Antiserum | Details |
| Recombinant Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) | Details |
| 2-Amino-1-(2,3-difluorophenyl)ethanone hydrochloride | C8H8ClF2NO | 1980062-95-0 | Details |
| 3-Iodo-1,5-dimethyl-1H-pyrazole | C5H7IN2 | 1354706-38-9 | Details |
| 3-(3,5-Difluoro-4-methoxyphenyl)propanal | C10H10F2O2 | 1036396-36-7 | Details |
| p53 antibody (Ser392) | Details |
| 1-Hydroxy-2-methylbicyclo[3.3.1]nonan-3-one | C10H16O2 | 74262-51-4 | Details |
| 4-(N-Methyl4-acetylbenzenesulfonamido)butanoic acid | C13H17NO5S | 847744-09-6 | Details |
| 2-Methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)propan-1-amine | C7H14N4 | 1016753-32-4 | Details |
| WDSOF1 antibody | Details |
| 1-Amino-2-(furan-2-yl)propan-2-ol | C7H11NO2 | 933726-05-7 | Details |
| Human IgE ELISA Kit | Details |
| 4-({4-[2-(Pyrrolidin-1-yl)ethyl]piperazin-1-yl}sulfonyl)benzoic acid | C17H25N3O4S | 1203428-11-8 | Details |
| Product Total： Product Page： | ||||
| 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 | ||||